Spectral AI, Inc. (NASDAQ:MDAI – Free Report) – Investment analysts at Zacks Small Cap increased their FY2025 EPS estimates for shares of Spectral AI in a research report issued to clients and investors on Wednesday, April 2nd. Zacks Small Cap analyst J. Vandermosten now anticipates that the company will post earnings per share of ($0.45) for the year, up from their previous estimate of ($0.57). The consensus estimate for Spectral AI’s current full-year earnings is ($0.48) per share. Zacks Small Cap also issued estimates for Spectral AI’s FY2026 earnings at ($0.18) EPS and FY2026 earnings at ($0.18) EPS.
Separately, HC Wainwright reissued a “buy” rating and issued a $3.50 price target on shares of Spectral AI in a report on Wednesday.
Spectral AI Stock Performance
Shares of Spectral AI stock opened at $1.21 on Friday. The company’s 50 day moving average price is $1.69 and its 200-day moving average price is $1.67. Spectral AI has a 52-week low of $0.82 and a 52-week high of $3.25. The stock has a market capitalization of $28.13 million, a price-to-earnings ratio of -1.86 and a beta of 0.62.
Spectral AI (NASDAQ:MDAI – Get Free Report) last announced its quarterly earnings data on Thursday, March 27th. The company reported ($0.06) earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of ($0.13) by $0.07. The company had revenue of $7.60 million for the quarter, compared to the consensus estimate of $6.83 million.
Institutional Inflows and Outflows
Several institutional investors have recently added to or reduced their stakes in MDAI. Virtu Financial LLC bought a new position in Spectral AI in the fourth quarter worth about $38,000. Northern Trust Corp purchased a new position in shares of Spectral AI in the 4th quarter valued at approximately $44,000. Millington Financial Advisors LLC bought a new stake in shares of Spectral AI during the fourth quarter valued at approximately $85,000. Jane Street Group LLC purchased a new stake in Spectral AI in the fourth quarter worth $92,000. Finally, Renaissance Technologies LLC bought a new position in Spectral AI in the fourth quarter worth $272,000. 67.08% of the stock is currently owned by institutional investors.
About Spectral AI
Spectral AI, Inc, an artificial intelligence (AI) company, focuses on developing predictive medical diagnostics in the United States. The company develops medical diagnostics for faster and accurate treatment decisions in wound care with applications involving patients with burns and diabetic foot ulcers.
See Also
- Five stocks we like better than Spectral AI
- What does consumer price index measure?
- Archer Aviation’s Africa Deal Could Boost ACHR Stock
- What Are Growth Stocks and Investing in Them
- Are Short Sellers Wrong About These 3 Semiconductor Stocks?
- What to Know About Investing in Penny Stocks
- Boeing Gets $50B in March Orders—Is BA Stock a Buy Now?
Receive News & Ratings for Spectral AI Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Spectral AI and related companies with MarketBeat.com's FREE daily email newsletter.